Better Choice to Participate at the 10th Annual ROTH Deer Valley Corporate Access Event on Thursday, December 9th
Management will also host a webinar on Friday, December 10th at 2:00 p.m. ETNEW YORK, Dec. 02, 2021 (GLOBE NEWSWIRE)...
News
Launch of Tilray’s Fast-Acting Oral Strips Highlights Commitment to Medical Cannabis Innovation and Patient Care
Aphria Branded Medical Cannabis Oral Strips Powered by QuickStrip™ Innovation Now Available to Patients Throughout CanadaNEW YORK and LEAMINGTON, Ontario,...
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
Anticipate First Patient Dosing in Phase 1/2 Clinical Trial for XTX202, a Tumor-Selective IL-2, in First Quarter of 2022 Advancing...
Plus Therapeutics to Present at MedInvest Oncology Investor Conference
AUSTIN, Texas, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative,...
Psyence Group Functional Mushroom Brand “GOODMIND™” Commences National Roll-Out in South Africa’s Largest Coffee Retail Chain
Company Broadens Revenue Generation Initiatives GOODMIND™ Elevate your daily grind / GOODMIND™ TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Psyence...
Shattuck Labs to Present at TIGIT Therapies Digital Summit 2021
AUSTIN, TX and DURHAM, NC, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering...
Aurora Spine Corporation Retains PRIA Healthcare to Improve Patient Access to Proprietary Products
CARLSBAD, Calif. , Dec. 02, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB:...
Kraig Biocraft Laboratories Begins Production of Fourth Generation Recombinant Spider Silk Silkworms in New Production Headquarters
ANN ARBOR, Mich., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”),...
Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7
NEW YORK and SALT LAKE CITY, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced...
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies
- Completion of facility supports upcoming clinical milestones including expected multiple fourth quarter IND filings -WALTHAM, Mass., Dec. 02, 2021...
ProMIS Neurosciences Shareholders Approve Special Resolution
TORONTO and CAMBRIDGE, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (the “Company”), a...
Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104
Bioavailability of GTX-104 compares favorably with the oral formulation of nimodipine; full PK study expected to report out as planned...
Surface Oncology to Present New Clinical Data from Ongoing SRF617 Phase 1 Trial at the European Society for Medical Oncology Immuno-Oncology Congress (ESMO-IO) 2021
CAMBRIDGE, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that...
Praxis Precision Medicines Announces Management Team Appointments
BOSTON, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB:...
Zentalis Pharmaceuticals to Host Virtual Research and Development (R&D) Day on December 16, 2021
Webcast to be held on Thursday, December 16 at 11:00 a.m. ESTNEW YORK and SAN DIEGO, Dec. 02, 2021 (GLOBE...
Recro to Present at Stephens Annual Investment Conference
Fireside Chat Webcast AvailableSAN DIEGO and GAINESVILLE, Ga., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a...
Skylight Health Announces Pricing of Public Offering of 275,000 Shares of Series A Cumulative Redeemable Perpetual Preferred Stock
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (NASDAQ:SLHG; TSXV: SLHG) (“Skylight Health” or the “Company”), a...
CareDx The Transplant Company Surpasses 80,000 Patient Milestone
Over 80,000 Heart, Kidney, and Lung Organ Transplant Recipients Have Used AlloSure or AlloMap in their Post-Transplant CareSOUTH SAN FRANCISCO,...
XORTX Therapeutics Appoints Altasciences as CRO for Clinical Study
CALGARY, Alberta, Dec. 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
